Pediatric Endocrine Society Provides Guidance for Growth Hormone Use in Pediatric Patients
The guidelines focused on idiopathic short stature, growth hormone deficiency, and primary IGF-I deficiency.
The guidelines focused on idiopathic short stature, growth hormone deficiency, and primary IGF-I deficiency.
Chronic hypopituitarism was noted in 44% of US veterans with mild traumatic brain injury.
However, researcher says high cost, need to get shots in clinics make it an unlikely osteoporosis treatment.
The FDA has approved the FlexPro PenMate is intended for users of Norditropin, which is indicated for patients with growth hormone-related disorders, who prefer hidden needles during injection.
Use of performance-enhancing substances are not just bad for the image of sport, but they also don’t improve athletes’ performance.
Ferring announced that the FDA has approved the name changes of its newly acquired products to be marketed as Zomacton (somatropin [rDNA origin]; formerly Tev-Tropin) for injection, and the needle-free delivery system as Zoma-Jet (formerly Tjet).
Researchers have discovered a single gene in a region of the X chromosome that may cause excessive growth in children.
The Endocrine Society has issued a clinical practice guideline for the diagnosis and treatment of acromegaly.
Cardiovascular morbidity and mortality may be increased in people with higher values of fasting growth hormone.
Patients with growth hormone deficiency reaped significant benefits in quality of live over the long term.